Blood protein inhibits cancer growth

1 July 2013

A study has found that a protein occurring naturally in the blood inhibits the growth of tumours.

Published in the Proceedings of the National Academy of Sciences, the study indicates that decorin could potentially be used as a means of cancer treatment.

Previous research has found that the protein affects the healing of wounds, the formation of new blood vessels from old ones and inflammatory responses.

But the senior investigator on this new study, Renato Iozzo, says that decorin is also a “soluble tumour repressor” - the first to be found that specifically targets new blood vessels which are being forced by the cancer to keep growing. By forcing the cells in the blood vessel to “eat” their own internal components, the protein reduces the risk that they might feed the cancer overall.

Dr Iozzo described the study’s results as “an exciting finding that we believe will open up a new avenue for both basic research and clinical application”.

Posted by Philip Briggs


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)